RealVNC mid-banner general
Advertisement: RSM
Advertisement: Mogrify
Advertisement: TTP
RealVNC mid banner careers
Mid banner advertisement: BDO
Advertisement: Cambridge Network
ARM Innovation Hub
Advertisement EY mid banner
Advertisement: Wild Knight Vodka
Barr Ellison Solicitors – commercial property
Advertisement Cambridge China Centre
Advertisement: Bradfield Centre mid
27 January, 2014 - 13:40 By News Desk

Innova Biosciences in alliance with TGR

Innova-Bioscences

Cambridge based Innova Biosciences has formed a significant collaboration with Australian life sciences company TGR BioSciences Pty Ltd (TGR).

TGR is focused on the development of rapid, high sensitivity ELISA systems using its CaptSure technology. Innova is a specialist provider of bioconjugation systems. The enzyme-linked immunosorbent assay (ELISA) is a test that uses antibodies and color change to identify a substance.

The firms have agreed to promote and co-market each other’s highly complementary technologies, providing customers with a major step forward in simplifying the ELISA development process, while improving sensitivity and reducing costs.

TGR has determined that combining Innova’s Lightning-Link conjugation kits for the horseradish peroxidase (HRP) labelling of antibodies with its CaptSure technology in the development of ELISA systems maximises assay sensitivity, whilst enabling the development of a wide range of ELISA assays rapidly and cost effectively.

As part of the deal Innova customers will be introduced to the CaptSure technology, with the assurance that it will work alongside the Lightning-Link reagents. Similarly, TGR customers will receive a recommendation for Lightning-Link, with the knowledge that it will be available for licensing to them, should they choose to use it alongside CaptSure products.

TGR’s CaptSure technology simplifies ELISA assays to one-step procedures, making them much faster and easier to carry out. Both assay antibodies are added to analyte at once, and after a single wash step the HRP substrate is added to develop the signal.

Importantly, costs of manufacture are greatly reduced, since only a single assay plate is required (coated with CaptSure reagent) rather than a different plate for each target, and the system also requires much less assay antibodies.

Innova’s Lightning-Link conjugation system provides the ability to label antibodies with only 30 seconds hands-on time, whilst offering 100% yields and enhanced sensitivity over traditional labelling techniques and over other conjugation systems on the market.

Dr Michael Crouch, director of business development at TGR, said: “We’ve been impressed with Innova’s products. Their HRP conjugation kit is simple to use and at the same time provides performance that exceeds that of a range of other systems that we have tested.”

Dr Andy Lane, executive director at Innova Biosciences, added: “We are pleased to further develop our relationship with TGR. Their CaptSure technology provides advantages in ELISA assay development that are directly complementary to the ethos of our conjugation technology – simplicity, high speed and enhanced sensitivity.”

Add new comment

Newsletter Subscription

Stay informed of the latest news and features